Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer von Verschraegen, C.F., Czok, S., Muller, C.Y., Boyd, L., Lee, S.J., Rutledge, T., Blank, S., Pothuri, B., Eberhardt, S., Muggia, F.

Volltext

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen von Verschraegen, C.F., Arias-Pulido, H., Lee, S.-J., Movva, S., Cerilli, L.A., Eberhardt, S., Schmit, B., Quinn, R., Muller, C.Y., Rabinowitz, I., Purdy, M., Snyder, D., Bocklage, T.

Volltext

Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470 von Kudelka, Andrzej P, Verschraegen, Claire F, Loyer, Evelyn

Volltext

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix von VERSCHRAEGEN, C. F, LEVY, T, KIEBACK, D, FISHMAN, A, KAVANAGH, J. J, KUDELKA, A. P, LLERENA, E, ENDE, K, FREEDMAN, R. S, EDWARDS, C. L, HORD, M, STEGER, M, KAPLAN, A. L

Volltext

Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma von Verschraegen, C F, Sittisomwong, T, Kudelka, A P, Guedes, E d, Steger, M, Nelson-Taylor, T, Vincent, M, Rogers, R, Atkinson, E N, Kavanagh, J J

Volltext

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix von KUDELKA, A. P, LEVY, T, JAECKLE, K. A, LOYER, E, STEGER, M, MANTE, R, MAVLIGIT, G, KILLIAN, A, TANG, R. A, GUTTERMAN, J. U, KAVANAGH, J. J, VERSCHRAEGEN, C. F, EDWARDS, C. L, PIAMSOMBOON, S, TERMRUNGRUANGLERT, W, FREEDMAN, R. S, KAPLAN, A. L, KIEBACK, D. G, MEYERS, C. A

Volltext

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines von MELICHAR, B, FERRANDINA, G, VERSCHRAEGEN, C. F, LOERCHER, A, ABBRUZZESE, J. L, FREEDMAN, R. S

Volltext

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors von Hu, W, McCrea, P D, Deavers, M, Kavanagh, J J, Kudelka, A P, Verschraegen, C F

Volltext

Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles von VERSCHRAEGEN, C. F, KUMAGAI, S, DAVIDSON, R, FEIG, B, MANSFIELD, P, LEE, S. J, MACLEAN, D. S, HU, W, KHOKHAR, A. R, SIDDIK, Z. H

Volltext

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later von Verschraegen, C. F., Benjapibal, M., Supakarapongkul, W., Levy, L. B., Ross, M., Atkinson, E. N., Bodurka‐Bevers, D., Kavanagh, J. J., Kudelka, A. P., Legha, S. S.

Volltext

Paraneoplastic syndromes of gynecologic neoplasms von ASHOUR, A. A, VERSCHRAEGEN, C. F, KUDELKA, A. P, KAVANAGH, J. J

Volltext

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum von KAVANAGH, J. J, KUDELKA, A. P, EDWARDS, C. L, FREEDMAN, R. S, VERSCHRAEGEN, C. F, DE LEON, C. G, TRESUKOSOL, D, HORD, D, FINNEGAN, M. B, KIM, E. E, VARMA, D, FORMAN, A, COHEN, P

Volltext

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour‐infiltrating lym... von NASH, M. A, LENZI, R, EDWARDS, C. L, KAVANAGH, J. J, KUDELKA, A. P, VERSCHRAEGEN, C. F, PLATSOUCAS, C. D, FREEDMAN, R. S

Volltext

Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Malignancies in the Lungs von VERSCHRAEGEN, C. F., GILBERT, B. E., HUARINGA, A. J., NEWMAN, R., HARRIS, N., LEYVA, F. J., KEUS, L., CAMPBELL, K., NELSON-TAYLOR, T., KNIGHT, V.

Volltext

Cytotoxic Activity of the Recombinant Anti-mesothelin Immunotoxin, SS1(dsFv)PE38, Towards Tumor Cell Lines Established from Ascites of Patients with Peritoneal Mesotheliomas von Li, Qian, Verschraegen, Claire F, Mendoza, John, Hassan, Raffit

Volltext

Octreotide induced remission of a refractory small cell carcinoma of the endometrium von VERSCHRAEGEN, C F, MATEI, C, LOYER, E, MALPICA, A, TORNOS, C, KUDELKA, A P, KAVANAGH, J J

Volltext

Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro von FERRANDINA, G, MELICHAR, B, LOERCHER, A, VERSCHRAEGEN, C. F, KUDELKA, A. P, EDWARDS, C. L, SCAMBIA, G, KAVANAGH, J. J, ABBRUZZESE, J. L, FREEDMAN, R. S

Volltext

Alternative Administration of Camptothecin Analogues von VERSCHRAEGEN, C. F., JAECKLE, K., GIOVANELLA, B., KNIGHT, V., GILBERT, B. E.

Volltext

Effects of interleukin-1α on ovarian carcinoma in patients with recurrent disease von Verschraegen, C.F., Kudelka, A.P., Termrungruanglert, W., de Leon, C.G., Edwards, C.L., Freedman, R.S., Kavanagh, J.J., Vadhan-Raj, S.

Volltext

Quantification of the Breakpoint Cluster Region Rearrangement for Clinical Monitoring in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia von Verschraegen, Claire F., Talpaz, Moshe, Hirsch-Ginsberg, Cherryl F., Pherwani, Rakesh, Rios, Mary B., Stass, Sanford A., Kantarjian, Hagop M.

Volltext